SYL040012

· Sylentis, S.A.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SYL040012, covering 2010-10-22 to 2020-11-04. Get the full timeline:

Most recent: Clinical Trial Update: SYL040012, Treatment for Open Angle Glaucoma [Phase 2]